Mesoblast MEOBF
NASDAQ MEOBF
$1.90 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Mesoblast (MEOBF) Receivables - Other (2017 - 2026)

Mesoblast's (MEOBF) quarterly Receivables - Other came in at $1000.0 in Q2 2026, down 99.47% year-over-year from $190000.0 in Q2 2025, and down 100.0% quarter-over-quarter from $28.0 million in Q4 2025.

Analysis

Mesoblast (MEOBF) Receivables - Other (2017 - 2026) Analysis & Trends

Mesoblast has disclosed Receivables - Other across 6 years of filings, most recently posting $1000.0 for Q2 2026.

  • In Q2 2026, Receivables - Other fell 99.47% year-over-year to $1000.0; the TTM figure through Jun 2026 stood at $1000.0 (down 99.47% YoY), while the FY2026 annual figure was $1000.0, down 99.98% from the prior year.
  • Receivables - Other came in at $1000.0 for Q2 2026 at Mesoblast, down from $28.0 million in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $28.0 million in Q4 2025 to a low of $1000.0 in Q2 2026.
  • Average Receivables - Other over 3 years is $7.6 million, with a median of $3.1 million recorded in 2024.
  • Year-over-year, Receivables - Other jumped 815.21% in 2025 and slumped 99.47% in 2026.
  • Over 3 years, Receivables - Other stood at $3.1 million in 2024, then jumped by 815.21% to $28.0 million in 2025, then plunged by 100.0% to $1000.0 in 2026.
  • Per Business Quant data, the three most recent Receivables - Other figures were $1000.0 in Q2 2026, $28.0 million in Q4 2025, and $190000.0 in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Krystal Biotech 10.27 Bn 9.43 Bn 112.79 Mn
2 CRISPR Therapeutics AG 5.17 Bn 5.17 Bn -
3 Iovance Biotherapeutics 3.79 Bn 3.49 Bn 55.72 Mn
4 Legend Biotech 3.68 Bn 2.71 Bn 251.50 Mn
5 uniQure 3.05 Bn 3.05 Bn 5.49 Mn
6 Beam Therapeutics 2.65 Bn 2.65 Bn -
7 Precigen 2.44 Bn 2.44 Bn 52.17 Mn
8 Sarepta Therapeutics 2.33 Bn 1.53 Bn 251.87 Mn
9 Vericel 1.99 Bn 1.83 Bn 56.40 Mn
10 Mesoblast 246.02 Mn 143.11 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1,000.00
Dec 31, 2025 28.03 Mn
Jun 30, 2025 190,000.00
Dec 31, 2024 3.06 Mn
Jun 30, 2024 6.78 Mn
Jun 30, 2019 1.50 Mn
Mar 31, 2019 134,000.00
Dec 31, 2018 93,000.00
Sep 30, 2018 242,000.00
Jun 30, 2018 615,000.00
Mar 31, 2018 1.01 Mn
Dec 31, 2017 1.47 Mn
Sep 30, 2017 196,000.00
Jun 30, 2017 698,000.00